
Square dealing: Jiang Zemin dies
The Intelligence from The Economist
00:00
Breakthroughs in Alzheimer's Treatment
This chapter explores recent clinical trial results for the drug licanumab, indicating a significant reduction in Alzheimer's symptom progression. It reflects on the implications of the amyloid hypothesis, the challenges of drug accessibility, and the complex factors influencing the disease's development.
Transcript
Play full episode